Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation
NCT: NCT07786649 · RECRUITING
Brief Summary
This study aims to improve brain stimulation techniques for stroke patients dealing with motor and language issues. Researchers believe that current practices lack clarity because patients aren't grouped effectively and stimulation methods vary widely. The study will include 250 participants from Alexandra Hospital and National University Hospital. Once someone is eligible and agrees to join, they'll first undergo a baseline assessment to evaluate their condition. After that, they'll receive non-invasive brain stimulation (NIBS) over the course of a month. Participants will be assigned to specific NIBS treatments-either transcranial direct current stimulation (tDCS) or repetitive transcranial magnetic stimulation (rTMS)-based on their rehabilitation goals, medical history, and initial assessment results. Those needing to improve upper or lower limb movement, alleviate language difficulties (aphasia), or address neglect will receive tailored interventions: 20 sessions of tDCS or 12 sessions of rTMS. After the treatment, participants will be assessed again immediately and then six weeks later to measure any changes in their condition.
Frequently Asked Questions
What is Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation?
Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation is a clinical trial registered under NCT07786649. Current status: RECRUITING.
What is the status of NCT07786649?
The current status of NCT07786649 (Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation) is: RECRUITING.
When did Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation start?
Evaluating Different Protocols of Non-invasive Brain Stimulation (NIBS) in Stroke Rehabilitation started on 2024-08-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.